ADVERTISEMENT
UPDATED
Ebola, virus, Guinea, West Africa, outbreak
Ebola Outbreak in Guinea Originated from Past Epidemic
Genetic analyses suggest that the virus came from a patient who survived the 2013–2016 West African outbreak.
Ebola Outbreak in Guinea Originated from Past Epidemic
Ebola Outbreak in Guinea Originated from Past Epidemic

Genetic analyses suggest that the virus came from a patient who survived the 2013–2016 West African outbreak.

Genetic analyses suggest that the virus came from a patient who survived the 2013–2016 West African outbreak.

virus, cell & molecular biology, microbiology

COVID-19, SARS-CoV-2, coronavirus, pandemic, vaccine, vaccine trials, combination, mix and match, immunity, antibodies, T cells, Pfizer, Moderna, AstraZeneca, clinical trials
COVID-19 Vaccine Combos Aim to Boost Immunity
Asher Jones | Mar 9, 2021 | 6 min read
Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.
COVID-19, SARS-CoV-2, pandemic, research, reverse genetics, toolkit, antibodies, RNA
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Asher Jones | Mar 3, 2021 | 6 min read
Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.
Sex Differences in Immune Responses to Viral Infection
Catherine Offord | Mar 1, 2021 | 10+ min read
Stronger interferon production, greater T cell activation, and increased susceptibility to autoimmunity are just some of the ways that females seem to differ from males.
Alterations in Immune Genes Make Bats Great Viral Hosts
Abby Olena, PhD | Oct 27, 2020 | 3 min read
Bat species use different strategies to dampen immune activation in response to viruses.
SARS-CoV-2 Disables Key Components of Human Cells’ Defense System
Catherine Offord | Oct 22, 2020 | 4 min read
Researchers detail how viral proteins interact with host RNA to disrupt the cell’s ability to fight back against infection.
Blood Pressure Meds Point the Way to Possible COVID-19 Treatment
Ashley Yeager | Apr 2, 2020 | 7 min read
There is little evidence that antihypertensive drugs worsen COVID-19, and scientists are instead exploring the idea that such medications—or their downstream effects—may actually alleviate symptoms.
Zika Grabs Neural Stem Cell Protein to Cause Damage
Jef Akst | Jun 1, 2017 | 2 min read
The new findings, obtained from cell culture experiments, could explain the link between infection with the virus during pregnancy and infant microcephaly.
ADVERTISEMENT